UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): MARCH 19, 1997
INAMED CORPORATION
(Exact name of registrant as specified in its charter)
FLORIDA 1-9741 59-0920629
(State or other jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
3800 Howard Hughes Parkway
Suite 900
LAS VEGAS, NEVADA 89109
(address of principal executive offices) Zip Code
Registrant's telephone number, including area code: 702-791-3388
N/A
(former name or former address, if changed since last report)
<PAGE>
ITEM 5. OTHER EVENTS
On April 1, 1997, the Company issued a press released announcing
that the Board of Directors set July 1, 1997 as the date for the Company's
annual shareholder meeting. In the release the Company also announced certain
management and director changes including that Michael D. Farney resigned as
Director and Chief Financial Officer of the Company; that Donald K. McGhan has
assumed the role of Chief Executive Officer and Jim J. McGhan has been
appointed President and a Director. Harrison E. Bull, Esq., Richard Talley and
John E. Williams, M.D., F.A.C.S. were appointed Directors of the Company.
Willem Oost-Lievense, who had served as the Company's Chief Financial Officer,
left INAMED as of March 19, 1997. Samuel L. Simmons, Jr., Vice President of
Finance was appointed Treasurer and along with Karyn G. Hyland-Cotto, INAMED's
Financial Controller, will assume responsibility for the Company's financial
reporting. Jeff J. Barber has been promoted to Executive Vice President and
Director of Corporate Development.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements of Business Acquired.
Not applicable
(b) Pro Forma Financial Information
Not applicable
(c) Exhibits
See Exhibit Index.
The following exhibits are filed as part of this report:
Exhibit Exhibit Sequential
NUMBER DESCRIPTION PAGE NUMBER
99.1 Press Release 4
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
INAMED CORPORATION
a Florida corporation
(Registrant)
Date: April 1, 1997 By: /S/ DONALD K. MCGHAN
Donald K. McGhan
Chairman and Chief Executive Officer
<PAGE>
EXHIBIT 99.1
PRESS RELEASE
COMPANY CONTACT: Donald K. McGhan, Chairman, C.E.O
(702) 791-3388
AGENCY CONTACT: Jimmy Caplan
(805) 569-0076
INAMED CORPORATION SETS SHAREHOLDERS' MEETING
COMPANY ANNOUNCES APPOINTMENT OF NEW OFFICERS AND DIRECTORS
LAS VEGAS -- April 1, 1997 - INAMED Corporation (NASDAQ: IMDC; PSE: INA),
headquartered here, today announced that the board of directors set July 1,
1997 as the date for the company's annual shareholders' meeting. The
meeting will be held at 9:00 a.m. PDT at the Four Seasons Hotel in Santa
Barbara, California. The company also announced that the board had
established April 21, 1997 as the record date for the meeting.
The company also announced on March 31, 1997, Michael D. Farney resigned
his position as Director and Chief Executive Officer of the company. Mr.
Farney will continue to serve the company as an outside consultant and will
focus his efforts exclusively on resolving the company's breast implant
litigation. Donald K. McGhan, who remains Chairman of the company, has
assumed the role of Chief Executive Officer. Jim J. McGhan has been
appointed President and Director of INAMED Corporation and will continue to
serve as Chief Executive Officer of McGhan Medical Corporation, INAMED
Corporation's primary subsidiary.
INAMED Corporation also announced that the following three individuals were
appointed outside directors of the company: Harrison E. Bull, Esq., of
Santa Barbara, California, W. Richard Talley of Irvine, California, and
John E. Williams, M.D., F.A.C.S. of Los Angeles, California. They join
Donald K. McGhan and Jim J. McGhan on the company's expanded five-member
board of directors.
The company further announced that Willem Oost-Lievense, who had served as
the company's Chief Financial Officer, left INAMED on March 19, 1997.
Samuel L. Simmons, Jr., who is and remains Vice President of Finance, was
appointed Treasurer of the company and, along with Karyn G. Hyland-Cotto,
Inamed's Financial Controller, will assume responsibility for the company's
financial reporting. Additionally, Jeff J. Barber has been promoted to
Executive Vice President and Director of Corporate Development.
The Company also announced that due to efforts necessary to amend the
company's S-3 registration statement, INAMED Corporation filed a Form 12b-
25 Notification of Late Filing today with the Securities and Exchange
Commission relating to its 1996 10-K. The company will file its 1996 10-K
on or before April 15, 1997.
Inamed Corporation is a medical and surgical device company with 23
operating subsidiaries Worldwide. The company develops, manufactures and
markets medical devices for the plastic and reconstructive surgery,
bariatric surgery, and general surgery markets.
